Abstract
Antifibrinolytics in liver transplantation: they are effective, but what about the risk-benefit ratio?
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Paper Title
Journal
Date